Study to Investigate the Efficacy and Safety of an Oral Investigational Medication in Patients with Alopecia Areata
A clinical research study is currently looking for adults with moderate-to-severe alopecia areata to participate in a study to evaluate the safety and efficacy of an investigational drug. The study consists of an investigational oral drug that will be administered once daily, for 24 weeks. This investigational drug is experimental, and you will have 2 in 3 chance of receiving investigational drug and a 1 in 3 chance of receiving a placebo (an inactive pill). After the initial 24 weeks are completed, participants may receive the investigational drug for an additional 28 weeks where there will be no placebo.
During the study visits, several assessments and procedures will be conducted to assess your eligibility for the study. This study will last a period of up to 13 months and up to 15 visits. Your participation in this study is at no cost to you.
You may qualify to participate if you:
- are between 18 and 70 years old
- have alopecia areata
- have at least 50% scalp hair loss*
*study doctor will assess your amount of hair loss.
For more information about this study, please complete this form or contact the most convenient trial site listed below:
Investigate MD
Scottsdale, AZ, USA
Phone: 480-440-5985
University of California Irvine
Irvine, CA, USA
Phone: 949-824-7103
Stanford University
Redwood City, CA, USA
Phone: 650-497-3884
Yale School of Medicine
New Haven, CT, USA
Phone: 203-737-2861
Ameriderm Research
Ormond Beach, FL, USA
Phone: 386-523-0768
Michigan Center For Skin Care Research
Clinton Township, MI, USA
Phone: 586-286-7325
NW Dermatology Institute
Portland, OR, USA
Phone: 503-223-1933
International Clinical Research - Tennessee LLC
Murfreesboro, TN, USA
Phone: 615-410-3460
Progressive Clinical Research
San Antonio, TX, USA
Phone: 210-614-5557
Dermatology Specialists of Spokane
Spokane, WA, USA
Phone: 509-954-4366
Innovaderm Research
Montréal, QC, Canada
Phone: 514-521-3111
